$APPY Response from APPY Investor Relation Manager Jedidiah Mahan:
Jan 22 at 4:57 PM
David,
When we sent in the supplement in December, there were 53 days left of the 120 day goal that FDA has set for De Novo submissions, as Steve mentioned in the last investor call. Assuming that they achieve their goal, we would expect to hear from them by the end of January. For clarity, this is a performance goal set by the FDA, not necessarily a requirement.
Best,
Jed
Jedidiah Mahan
Investor Relations Manager
cid:27EB97BC-1228-4DF7-881B-DA86F2FEC85F@sd.cox.net
